Animal Parasiticides Market – By Product, By Type, By Animal Type, By Drug Class, By End Use & Global Forecast, 2025 – 2034

Animal Parasiticides Market Size

The global animal parasiticides market size was valued at USD 12.9 billion in 2024. The market is expected to grow from USD 13.7 billion in 2025 to USD 21.8 billion in 2034, at a CAGR of 5.3% from 2025 to 2034. The market is experiencing considerable growth driven by increasing animal population globally, high adoption of pet animals for companionship, rising cases of parasitic infections in animals, and growing expenditure on animal healthcare.
 

Contagious diseases such as tick-borne illnesses and intestinal parasites pose a threat to the health and well-being of animals, leading to a rising need for preventive and curative measures. According to an article published by the World Health Organization (WHO), in 2019, approximately 10,000 - 12,000 clinical cases of tick-borne encephalitis are reported each year. This rise in animal parasitic infectious diseases has prompted a greater emphasis on preventive healthcare, thereby increasing the demand for antiparasitic drugs.
 

Animal parasiticides, including topical solutions, oral medications, and injectables, serve as crucial tools for preventing parasitic infestations and controlling the spread of diseases. Pet owners are increasingly focused on ensuring the health and well-being of their animals. Also, the growing trend of pet ownership has further increased the demand for parasiticides for companion animals, such as dogs and cats. As per the World Animal Foundation estimates, the companion animal population reached approximately 967 million worldwide, of which 522 million were dogs and 445 million were cats.
 

Furthermore, growing livestock population and increasing consumption of animal-based products necessitates the use of antiparasitic drugs in farm animals. According to FAO, the global ruminant livestock population is roughly 3.6 billion, of which approximately 2 billion represents the total number of livestock animals used for meat and dairy products. These factors are poised to positively impact the market in the long term.
 

Further, several technological advancements in the field of veterinary medicine are set to positively influence the animal health industry. Recent developments such as telemedicine platforms and point-of-care diagnostics coupled with ongoing research and development activities in veterinary medicine is set to bring rapid expansion in the market.
 

Animal parasiticides are drugs that are used to kill parasitic organisms that threaten the health of farm and companion animals. These parasiticides are classified according to their mode of administration or usage. Parasiticides, including ectoparasiticides, endoparasiticides, and endectocides, are used to treat parasitic diseases.
 

Animal Parasiticides Market Trends

• The rise in animal healthcare expenditures serves as a significant growth driver for the market. According to the American Pet Products Association, in 2022, the U.S. spent USD 136.8 billion, of which around USD 58.1 billion was spent on pet food, USD 31.5 billion was spent on supplies and OTC medicine, USD 35.9 billion was spent on vet care and product sales, and USD 11.4 billion was spent on other services.
   
• This increasing spending on animal health positively impacts the revenue growth of veterinary clinics and hospitals, pharmaceutical companies, diagnostic laboratories, and other stakeholders within the animal parasiticides sector.
   
• Also, the rising trend of pet humanization and increased consumer spending on pet health, positively influences the animal parasiticides market growth. According to the European Pet Food Industry Federation (FEDIAF), pet ownership has grown to include 90 million European households, meaning that 46% of households own a companion animal.
   
• Similarly, as per the American Pet Products Association (APPA) 2022 survey, over 66% of U.S. households own at least one pet. This means over 86.9 million homes own a pet. Thus, the increasing population of pets will boost the demand for market.
   
• Further, the rise in the global demand for livestock products owing to an increase in population, rising incomes, and urbanization, has boosted the population of livestock animals. As global demand for animal-derived protein continues to rise, the livestock industry faces challenges related to parasitic infestations that can negatively impact animal health and productivity.
   
• In response to this, there is a growing need for effective parasiticides to ensure the well-being of livestock and maintain the quality of animal-derived products.  According to an article published by Sentient Media, in 2023, the average person in the U.S. eats 347.36 g of meat every single day. The surge in demand for animal protein places greater emphasis on implementing robust parasitic control measures to safeguard the health and productivity of livestock.
   
• The increasing prevalence of zoonotic diseases globally is expected to positively influence the market growth. For instance, as per the Centers for Disease Control and Prevention (CDC) report, zoonotic diseases are very common, both in the U.S. and around the world.
   
• Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals. The increasing awareness of zoonotic diseases and their impact on human health has increased animal healthcare expenditures, boosting demand for the market.
   

Animal Parasiticides Market Analysis

Based on the product, the market is segmented into ectoparasiticides, endoparasiticides, and endectocides. The ectoparasiticides segment is further categorized into pour-ons and spot-ons, oral tablets, sprays, dips, ear tags, collars, and other ectoparasiticides. In 2024, ectoparasiticides segment accounted for highest market revenue of USD 7 billion.
 

• Ectoparasites such as fleas, ticks, and mites, pose serious health risks to animals. The prevalence of these external parasites, especially in regions with diverse climates, drives the consistent demand for ectoparasiticides drugs.  
   
• Pet owners and livestock farmers prioritize the use of these specialized parasiticides to protect animals from infestations. Also, ectoparasiticides are vital to the health and hygiene of pets and livestock because of their broad range of efficacy against external parasites.
   
• Developing novel formulations including spot-on treatments, sprays, and dips, have also helped boost the market growth by increasing adherence and compliance among pet owners and livestock farmers.
   
• Further, government programs and policies focused on ensuring animal health, especially veterinary medicine in livestock farming, have aided in maintaining a strong position in the market for ectoparasiticides. These features associated with ectoparasiticides will drive the preference of consumers to expedite the segmental growth in the coming years.
   

Based on the type, the animal parasiticides market is segmented into over the counter (OTC) and prescription. In 2024, prescription segment dominated the market with a market share of 74.1%.
 

• The prescription segment dominates the market owing to the rising cases of parasitic infections in companion animals and livestock.
   
• Prescription parasiticides require the involvement of a veterinarian, to ensure that the treatment plan is tailored to the specific needs and health condition of the animal. This reliance on professional expertise enhances the efficacy and safety of the parasiticide products.
   
• This segment, in comparison to over-the-counter products, is much more effective because prescription products tend to be more refined and tailored to treat specific types of parasitic infestations.
   
• Additionally, prescription-based parasiticides often offer more targeted and potent formulations, addressing specific parasite infestations or health concerns in animals.
   

Based on the animal type, the animal parasiticides market is classified into companion animals and farm animals. The companion animals segment held the highest revenue in 2024 with a market share of 56.9%. The companion animals segment is sub-segmented into dogs, cats, horses, and other companion animals.
 

• This substantial growth is attributed to the rising adoption rate of animals such as dogs, cats, birds, and horses as pets. More than half of the global population is estimated to have a pet at home. Dogs are the most popular pet, present in around one in three homes. Thus, the sheer number of companion animals along with increased spending is expected to propel the segmental growth.
   
• Similarly, there has been a significant increase in the incidence of various parasitic diseases among the companion animals. Preventing parasitic infestations in pets is considered a fundamental aspect of responsible pet ownership.
   
• Companion animals, including dogs and cats, are commonly affected by parasites such as fleas, ticks, mites, and worms. These parasites can cause a range of health issues, from skin irritation to serious diseases. This rising burden of parasitic infestations in pets translates to greater demand for animal parasiticides.
   
• Moreover, the increasing focus of manufacturers to develop and launch innovative animal parasiticides is set to further propel market growth.
   

Based on the drug class, the animal parasiticides market is classified into chemical synthetic, macrocyclic lactones, pyrethroids, organophosphates, benzimidazoles, and other drug classes. The chemical synthetic segment dominated the market in 2024 and is anticipated to witness growth at a CAGR of 5% over the forecast years.
 

• The market is dominated by the chemical synthetic segment because of its proven effectiveness, broad-spectrum activity, and cost-effectiveness.
   
• Chemical parasiticides like anthelmintics, ectoparasiticides, and endectocides are utilized extensively for the management of internal as well as external parasites for both livestock and companion animals. These products have a rapid action profile against a myriad of parasites, recovering the health of animals and increasing their productivity.
   
• Moreover, the use of these chemical parasiticides in veterinary practices, farms, and pet care establishments fosters their dominant position in the market.
   

Based on the end use, the animal parasiticides market is bifurcated into veterinary hospitals and clinics, animal farms, and home care settings. In 2024, the veterinary hospitals and clinics segment dominated the market and is expected to reach USD 12.7 billion by 2034.
 

• Veterinary hospitals and clinics are staffed with trained and licensed professionals, including veterinarians and veterinary technicians. This expertise ensures accurate diagnosis, prescription, and administration of parasiticides tailored to each animal's specific needs.
   
• Also, there is growing dependence of pet owners and livestock farmers on veterinary hospitals and clinics for efficient parasite eradication. The segment is driven by prescription-only access to parasiticides, advanced diagnostic procedures for parasitic infection, and other sophisticated treatment options available in veterinary hospitals and clinics.
   
• Further, these establishments offer a spectrum of healthcare services, making them one-stop destinations for pet owners. The growing adoption of pet insurance and increased expenditure on healthcare also add to the veterinary hospitals and clinics market share within the animal parasiticides industry.
   

North America animal parasiticides market held the largest market share of 37.2% in 2024 in the global market, and it is anticipated to expand at a 4% CAGR over the forecast period. The U.S. market was valued at USD 3.8 billion in 2021. The market size was valued at USD 3.9 billion in 2022 and reached USD 4.2 billion in 2023.
 

• According to the American Pet Products Association (APPA) 2021 data, U.S. pet ownership has been on the rise in recent years, with 67% of households in the owning a pet. Similarly, Americans are increasingly willing to invest in their furry companions, with total pet expenditures reaching USD 103.6 billion in 2020, a 6.7% increase from the previous year.
   
• Further, the country also boasts a high population of livestock animals. For instance, there were 87.2 million head of cattle and calves on the U.S. farms as of January 2024.
   
• Such high volume of companion and livestock animals in the country increases the demand for various animal pharmaceuticals including antiparasitic drugs, thus boosting the growth of the U.S. market.
   
• Further, increased government funding and support along with robust animal health policies in the U.S also assist in substantiating the high market share.
   

Europe animal parasiticides market accounted for USD 3.9 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• As per the European Pet Food Industry, approximately 90 million households in the EU own a pet (~46%). This rise in animal adoption in the European region coupled with increasing initiatives by government to improve animal healthcare is anticipated to spur market growth.
   
• Advancements in veterinary medicine with frequent introduction and approval of novel pharmaceuticals will boost the market in the Europe region.
   
• Also, the presence of key market players such as Boehringer Ingelheim, Elanco, and Virbac reinforce Europe’s strength in the market. These companies are actively participating in innovation through the development of new products like long-acting antiparasitic treatments and combination therapies for pets and livestock.
   

The Asia Pacific animal parasiticides market demonstrates significant growth potential of 6.6% CAGR during the analysis period.
 

• The market in the Asia Pacific region is growing rapidly due to the rise in pet ownership, advancements in animal health awareness, and the improvement of veterinary care infrastructure.
   
• Countries such as China, India, and Japan are becoming big consumers of parasiticides because of the expanding dairy and meat industries that demand high standards of parasite control for productivity and animal welfare.
   
• Furthermore, the diversity in climate and ecological conditions across countries in the Asia-Pacific region creates a varied landscape for parasitic challenges. This necessitates a wide range of parasiticide products to address the specific needs of different regions and animal species, contributing to the overall growth of the market.
   

Brazil animal parasiticides market is anticipated to witness rapid growth over the forecast years.
 

• Brazil is poised to expand rapidly within the Latin America market due to its advanced livestock sector and rising animal health product consumption. Being one of the world’s leading beef, poultry, and pork producers, Brazil’s animal husbandry practices require efficient parasiticides to safeguard the health and productivity of livestock.
   
• Also, the increasing trend of pet ownership, especially in urban areas, also fuels the need for companion animal parasiticides. In 2023, Brazil counted over 160 million pets, of which more than 62 million were dogs.
   
• Government policies and legislative support to enhance veterinary services and disease management in the country help to further boost the market, ensuring persistent adoption of antiparasitic agents among livestock and pet animals.
   

South Africa animal parasiticides market is set for considerable growth in the Middle East and Africa market.
 

• The market in South Africa has notable growth opportunities due to the increasing incidence of parasitic infections in livestock and pets. Parasitic infestations like ticks, worms, and mite infections pose a heavy economic burden on the country’s agriculture, especially in cattle, sheep, and poultry farming.
   
• Therefore, there is growing awareness among farmers and pet owners regarding the need for effective parasite control which drives the demand for antiparasitic drugs.
   
• Moreover, the supporting policies by the South African government for veterinary medicine enhances the country level market growth.
   

Animal Parasiticides Market Share

The market is highly competitive, with several key companies striving to develop novel formulations in the market. Top 4 companies in the market such as Zoetis Inc., Elanco Animal Health, Merck, and Boehringer Ingelheim International account for approximately 65% of the global market share. The key industry players are consistently involved in creating new opportunities in the healthcare sector.
 

Additionally, there are several local and regional players operating in the market are boosting competition by providing affordable options at lower costs. These players are also involved in several strategies such as mergers, acquisitions, and novel product launches to expand their product offerings. For instance, in November 2021, the European Commission approved Felpreva, Vetoquinol's new three-monthly feline parasiticide, for marketing. This approval increased the firm's product portfolio, which contributed to revenue growth.
 

Animal Parasiticides Market Companies

Prominent players operating in the animal parasiticides industry include:

• Boehringer Ingelheim International
• Bimeda
• Biogénesis Bagó
• Ceva Sante Animal
• Dechra Pharmaceuticals
• Elanco Animal Health
• Merck
• Norbrook Laboratories
• Neogen Corporation
• Ourofino Saúde Animal
• Phibro Animal Health
• PetIQ
• Virbac
• Vetoquinol
• Zoetis
   

Zoetis is one of the leading global animal health companies. The company discovers, develops, manufactures and commercializes a diverse portfolio of animal health medicines and vaccines and has operations in over100 countries. The company's dedication to R&D stimulates innovation in animal healthcare, allowing the launch of novel, effective, and safe treatments.
 

Boehringer Ingelheim has a notable presence in the animal parasiticides market. The company offers a wide array of products designed to improve animal health. In January 2021, Boehringer Ingelheim announced that it has received marketing authorization from the EMA (European Medicine Agency) and European Commission for its NexGard COMBO topical solution for cats. The NexGard COMBO offers protection for cats by killing a broader range of parasites. This product approval helped the company to acquire increased customer base.
 

Animal Parasiticides Industry News:

• In July 2023, Bimeda, Inc. launched SpectoGard (spectinomycin sulfate) sterile solution in the U.S. This is the first bioequivalent, generic spectinomycin sulfate injectable solution approved for use in cattle. This launch helped the company improve its market positioning in the market.
•  
• In July 2023, The Environmental Protection Agency (EPA) completed its review of the Seresto flea and tick collar and confirmed its continued registration, affirming the safety profile of the product. The collars have been found to meet the EPA's standards and provide important flea and tick prevention for dogs and cats, as well as lice control for dogs.
   
• In June 2023, Norbrook launched Tauramox (moxidectin) injectable solution in U.S. It is a ready-to-use injectable parasiticide containing 1% moxidectin, effective in treating and controlling gastrointestinal roundworms, lungworms, cattle grubs, mites, lice in beef cattle and non-lactating dairy cows. This product launch helped the company enhance its market positioning.
   
• In May 2023, Merck Animal Health announced that the Australian Pesticides and Veterinary Medicines Authority (APVMA) has authorized a unique injectable formulation of BRAVECTO (fluralaner) for the treatment and prevention of flea (Ctenocephalides felis) infestations for dogs for a time period of 12 months. This helped the company expand its product offerings in Australia.
   
• In January 2023, Merck Animal Health announced that the U.S. FDA approved an additional indication for BRAVECTO chews for dogs. The new indication cures and manages Asian long horned ticks, an invasive Ixodid species found in more than one-third of the U.S. This approval is expected to increase the sale of the BRAVECTO chews in coming years.
   

The animal parasiticides market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Ectoparasiticides     
  • Pour-ons and spot-ons
  • Oral tablets
  • Sprays
  • Dips
  • Ear tags
  • Collars
  • Other ectoparasiticides
• Endoparasiticides    
  • Oral liquids
  • Oral solids
  • Injectables
  • Feed additives
  • Other endoparasiticides
• Endectocides

Market, By Type

• Over the counter (OTC)
• Prescription

Market, By Animal Type

• Companion animals
  • Dogs
  • Cats
  • Horses
  • Other companion animals
• Farm animals
  • Swine
  • Cattle
  • Poultry
  • Sheep and goats
  • Other farm animals

Market, By Drug Class

• Chemical synthetic
• Macrocyclic lactones
• Pyrethroids
• Organophosphates
• Benzimidazoles
• Other drug classes

Market, By End Use

• Veterinary hospitals and clinics
• Animal farms
• Home care settings

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Poland
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Turkey